TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 80115310293

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80115310293 and manufactured by KOVALENT DO BRASIL LTDA. The registration is held by KOVALENT DO BRASIL LTDA with validity until Jun 19, 2033.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIO-RAD, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.